Results 71 to 80 of about 254,699 (197)

Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials

open access: yes, 2019
International audienceTo compare the efficacy and safety of intravenous immunoglobulins (IVIG) and anti-D immunoglobulin (anti-D) in pediatric immune thrombocytopenia (ITP)
Lioger, François   +6 more
core   +1 more source

Intravenous IgM-enriched immunoglobulins in critical COVID-19

open access: yes, 2022
\(\bf Background:\) A profound inflammation-mediated lung injury with long-term acute respiratory distress and high mortality is one of the major complications of critical COVID-19. Immunoglobulin M (IgM)-enriched immunoglobulins seem especially capable
Timmesfeld, Nina (Prof. Dr.)   +21 more
core   +1 more source

A pediatric case of multifocal motor neuropathy with the conduction block

open access: yesKhyber Medical University Journal
Background: Multifocal motor neuropathy with conduction block (MMNCB) is a rare immune-mediated motor neuropathy, predominantly seen in adults, with few pediatric cases reported.
Saba Zaidi, , Mahzareen
doaj   +1 more source

Polyneuritis cranialis: full recovery after intravenous immunoglobulins.

open access: yes, 2007
Polyneuritis cranialis is a rare disorder of multiple cranial nerve palsies without spinal cord involvement. The case reported is of a 10-year-old boy with multiple palsies involving cranial nerves III, IV, V, VI, VII, IX, X, XI, and XII cranial nerves ...
Incorpora G   +3 more
core  

Intravenous immunoglobulins--understanding properties and mechanisms

open access: yes, 2009
High-dose intravenous immunoglobulin (IVIg) preparations are used currently for the treatment of autoimmune or inflammatory diseases. Despite numerous studies demonstrating efficacy, the precise mode of action of IVIg remains unclear.
Rieben, R.   +20 more
core   +1 more source

Efficacy of combined intravenous immunoglobulins and steroids in children with primary immune thrombocytopenia and persistent bleeding symptoms.

open access: yes, 2014
Background. The aim of this study was to investigate the effect of the combined administration of intravenous immunoglobulins and steroids as a second-line therapy in 34 children with primary immune thrombocytopenia and persistent, symptomatic bleeding.
Matarese SM   +25 more
core   +1 more source

Comparative analysis of Intravenous medication errors in in-patients care - Globally : A systematic review study

open access: yes, 2020
Medication errors are the most prevalent form of medical errors, and intravenous medicines are at greater risk since their preparation and administration are complicated.
Khantoumani, Shahd
core  

Immunoglobulins for intravenous use inhibit TNF alpha cytotoxicity in vitro.

open access: yes, 1997
Intravenous immunoglobulins (IVIg) have been used as an immunomodulatory therapy in a variety of diseases. Several mechanisms of action have been proposed, one of which is interference with the cytokine network. We have investigated the effect of IVIg on
Marx, P   +4 more
core   +1 more source

Predictors of intravenous immunoglobulin therapy in juvenile idiopathic inflammatory myopathies

open access: yesTrends in Pediatrics
Objective: Juvenile idiopathic inflammatory myopathies (JIIM) exhibit heterogeneous presentation, and intravenous immunoglobulin (IVIG) is often required in refractory cases. This study aimed to identify the clinical characteristics associated with IVIG
Emine Özçelik   +11 more
doaj   +1 more source

PLASMAPHERESIS VERSUS INTRAVENOUS IMMUNOGLOBULINS IN GUILLAIN BARRE SYNDROME, THE THERAPEUTIC OUTCOMES

open access: yesPakistan Armed Forces Medical Journal, 2015
Objective: To compare the therapeutic outcomes of plasmapheresis with intravenous immunoglobulins (IVIG) for Guillain Barre syndrome. Study Design: Randomized controlled trial.
Syed Parvez Asghar   +4 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy